NIPH Clinical Trials Search

UMIN ID: C000000285

Registered date:18/11/2005

Searching research on senior citizen's gastric cancer on clinical effect and safety of TS-1

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedsenior citizen's gastric cancer
Date of first enrollment2004/06/01
Target sample size30
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)TS1: 50 or 80 or 100 or 120 mg/body/day, orally 28 days, every 6 weeks


Primary OutcomeResponse rate
Secondary OutcomeTTF, OS, Safety, Home treatment period, home treatment rate

Key inclusion & exclusion criteria

Age minimum75years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1.History of severe drug allergic reaction 2.Severe Bone marrow suppression,renal and liver function disturbance 3.Concomitant therapy with another anticancer drug or flucytocine 4.Marked pleural effusion or ascites 5.Symptomatic brain metastasis 6.Intestinal fresh hemorrhage 7.Active secondary cancer 8.Accompanied serious diseases 9.Severe Ischemic heart disease or Arrhythmia which requires treatment 10.Watery diarrhea 11.Decision as ineligible by principal investigator

Related Information


public contact
Address Japan
Affiliation The Tokyo cooperative Oncology Group Secretariat
scientific contact
Name Minoru Kurihara
Address 1-23-2 Hamamatsu-cho Minato-ku Tokyo Japan Japan
Affiliation The Tokyo cooperative Oncology Group Director